Related references
Note: Only part of the references are listed.Widely used gene editing strategies in cancer treatment a systematic review
Ahmed AbdulJabbar Suleiman et al.
GENE REPORTS (2021)
Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells
Wusheng Liu et al.
PLANT CELL REPORTS (2020)
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Yamin Li et al.
BIOMATERIALS (2020)
Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics
Fengqian Chen et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Hossein Rahimi et al.
NANO TODAY (2020)
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases
Jared Carlson-Stevermer et al.
NATURE COMMUNICATIONS (2020)
Efficient viral delivery of Cas9 into human safe harbor
Hideki Hayashi et al.
SCIENTIFIC REPORTS (2020)
Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System
Yagiz Alp Aksoy et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Daniel Rosenblum et al.
SCIENCE ADVANCES (2020)
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
Improving CRISPR Genome Editing by Engineering Guide RNAs
Su Bin Moon et al.
TRENDS IN BIOTECHNOLOGY (2019)
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Gregoire Cullot et al.
NATURE COMMUNICATIONS (2019)
Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
Joonsun Lee et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy
Peng Lv et al.
NANO LETTERS (2019)
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Ji Liu et al.
ADVANCED MATERIALS (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
CRISPR-Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Debarati Ghosh et al.
CANCER CELL INTERNATIONAL (2019)
Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing
Kyung Hyun Yoo et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2019)
Advances in genome editing through control of DNA repair pathways
Charles D. Yeh et al.
NATURE CELL BIOLOGY (2019)
Engineering of CRISPR-Cas12b for human genome editing
Jonathan Strecker et al.
NATURE COMMUNICATIONS (2019)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
CRISPR RNAs trigger innate immune responses in human cells
Sojung Kim et al.
GENOME RESEARCH (2018)
Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity
Hui Kwon Kim et al.
NATURE BIOTECHNOLOGY (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
Zoe N. Rogers et al.
NATURE GENETICS (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
A modular platform for targeted RNAi therapeutics
Ranit Kedmi et al.
NATURE NANOTECHNOLOGY (2018)
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
Hung-Chih Yang et al.
VIRUS RESEARCH (2018)
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
Jasper Edgar Neggers et al.
NATURE COMMUNICATIONS (2018)
The CRISPR tool kit for genome editing and beyond
Mazhar Adli
NATURE COMMUNICATIONS (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Yinnan Chen et al.
ADVANCED SCIENCE (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
Engineered CRISPR-Cas9 nuclease with expanded targeting space
Hiroshi Nishimasu et al.
SCIENCE (2018)
Directed evolution of CRISPR-Cas9 to increase its specificity
Jungjoon K. Lee et al.
NATURE COMMUNICATIONS (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Nuphar Veiga et al.
NATURE COMMUNICATIONS (2018)
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Martin Kampmann
ACS CHEMICAL BIOLOGY (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Cornerstones of CRISPR-Cas in drug discovery and therapy
Christof Fellmann et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice
Chun-Qing Song et al.
GASTROENTEROLOGY (2017)
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
Su Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles
Aisling J. O'Loughlin et al.
MOLECULAR THERAPY (2017)
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Janice S. Chen et al.
NATURE (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Genome editing reveals a role for OCT4 in human embryogenesis
Norah M. E. Fogarty et al.
NATURE (2017)
Engineered Cpf1 variants with altered PAM specificities
Linyi Gao et al.
NATURE BIOTECHNOLOGY (2017)
Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain
Jun Nishiyama et al.
NEURON (2017)
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy (vol 8, 14454, 2017)
Niclas E. Bengtsson et al.
NATURE COMMUNICATIONS (2017)
Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC
Deborah Y. Kwon et al.
NATURE COMMUNICATIONS (2017)
Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
Wenhan Yu et al.
NATURE COMMUNICATIONS (2017)
Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering
Kunwoo Lee et al.
ELIFE (2017)
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
Ann Lin et al.
ELIFE (2017)
CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials
Leonhard Kick et al.
BIOENGINEERED (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases
Julia Zischewski et al.
BIOTECHNOLOGY ADVANCES (2017)
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
Chao Jiang et al.
CELL RESEARCH (2017)
Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
June-Koo Lee et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Optimizing T-cell receptor gene therapy for hematologic malignancies
Emma C. Morris et al.
BLOOD (2016)
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Pedro Barata et al.
CANCER TREATMENT REVIEWS (2016)
Off-target effects of engineered nucleases
Jiing-Kuan Yee
FEBS JOURNAL (2016)
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
Stefano Annunziato et al.
GENES & DEVELOPMENT (2016)
Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
Josh Tycko et al.
MOLECULAR CELL (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
Christopher D. Richardson et al.
NATURE BIOTECHNOLOGY (2016)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases
Shengdar Q. Tsai et al.
NATURE REVIEWS GENETICS (2016)
Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation
Christian J. Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Keiji Nishida et al.
SCIENCE (2016)
Engineering Delivery Vehicles for Genome Editing
Christopher E. Nelson et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 7 (2016)
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
Roman Maresch et al.
NATURE COMMUNICATIONS (2016)
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
Faheem Ahmed Khan et al.
ONCOTARGET (2016)
Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases
Jean-Baptiste Renaud et al.
CELL REPORTS (2016)
Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
Martyn K. White et al.
PLOS PATHOGENS (2016)
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
Hong Chang et al.
SCIENTIFIC REPORTS (2016)
Adeno-associated virus-mediated cancer gene therapy: Current status
Jingfeng Luo et al.
CANCER LETTERS (2015)
Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds
Jesse G. Zalatan et al.
CELL (2015)
Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
Xiquan Liang et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver et al.
NATURE (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Takeshi Maruyama et al.
NATURE BIOTECHNOLOGY (2015)
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
Van Trung Chu et al.
NATURE BIOTECHNOLOGY (2015)
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
Isaac B. Hilton et al.
NATURE BIOTECHNOLOGY (2015)
Small molecule-triggered Cas9 protein with improved genome-editing specificity
Kevin M. Davis et al.
NATURE CHEMICAL BIOLOGY (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Marc Zuckermann et al.
NATURE COMMUNICATIONS (2015)
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
Francis Robert et al.
GENOME MEDICINE (2015)
Magnetic Nanoparticles: A Review of Chemical and Physical Characteristics Important in Medical Applications
Ali Yadollahpour et al.
ORIENTAL JOURNAL OF CHEMISTRY (2015)
DNA Sequencing of Cancer: What Have We Learned?
Juliann Chmielecki et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
CRISPR/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox
Elena Senis et al.
BIOTECHNOLOGY JOURNAL (2014)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Luke A. Gilbert et al.
CELL (2014)
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Wen Xue et al.
NATURE (2014)
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander et al.
NATURE BIOTECHNOLOGY (2014)
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
Dirk Heck et al.
NATURE BIOTECHNOLOGY (2014)
DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells
Yegor Smurnyy et al.
NATURE CHEMICAL BIOLOGY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Steven Lin et al.
ELIFE (2014)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
INNOVATION TALENs: a widely applicable technology for targeted genome editing
J. Keith Joung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques
Karen Nieto et al.
HUMAN GENE THERAPY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva et al.
NATURE (2011)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
The repetitive DNA elements called CRISPRs and their associated genes: Evidence of horizontal transfer among prokaryotes
James S. Godde et al.
JOURNAL OF MOLECULAR EVOLUTION (2006)
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin
A Bolotin et al.
MICROBIOLOGY-SGM (2005)
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies
C Pourcel et al.
MICROBIOLOGY-SGM (2005)
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements
FJM Mojica et al.
JOURNAL OF MOLECULAR EVOLUTION (2005)
Mechanism and regulation of human non-homologous DNA end-joining
MR Lieber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Solid lipid nanoparticles -: Production, characterization and applications
W Mehnert et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
